Walgram Tanja, Attigah Nicolas, Schwegler Igor, Weber Markus, Dzemali Omer, Berthold Christian, Wagnetz Dirk, Carboni Giovanni L
Division of Thoracic Surgery, Department of Surgery, Triemli Hospital Zurich, Switzerland.
Division of Vascular Surgery, Department of Surgery, Triemli Hospital Zurich, Switzerland.
Interact Cardiovasc Thorac Surg. 2018 Apr 1;26(4):545-550. doi: 10.1093/icvts/ivx364.
Tumour infiltration, or gross infectious involvement of the thoracic aortic wall, poses a significant intraoperative risk for fatal bleeding and therefore could compromise adequate resection or efficient surgical management of pleural infection in a considerable amount of cases. We present 3 successful cases of off-label thoracic aortic endografting to safeguard thoracic aortic wall integrity.
After all patients received thoracic stent grafts through femoral access into the descending aorta, the first patient underwent a resection of a locally advanced squamous cell carcinoma of the left inferior lobe cT4cN0-1cM0 after neoadjuvant chemoradiation, which had infiltrated the descending aortic wall. The second case was video-assisted thoracoscopic bilateral pleural decortication for empyema with aortic ulcers of the distal thoracic aorta in a patient with pancreatic intrathoracic fistula in a necrotizing pancreatitis. The third patient was operated for a locally advanced squamous cell carcinoma of the left inferior lobe initial stage cT4 cN1-2 cM0 after neoadjuvant chemoradiation, which had broad contact to the descending aorta at the level of thoracic vertebrae 7 and 8 on a circumference of circa 180°. Regional ethics committee approval according the Swiss Federal Human Research Act was obtained according to regulations.
Preventive stent graft placement resulted in complication-free resection and significantly minimized the risk of fatal intraoperative bleeding. Patients were thus not exposed to complications associated with aortic cross-clamping, possible prosthetic replacement and extracorporeal circulation techniques.
In carefully selected patient populations, the resection of locally advanced tumours or infectious processes involving the aortic wall can be facilitated by thoracic endovascular aortic repair prior to resection.
肿瘤浸润或胸主动脉壁的严重感染累及,会带来致命性出血的重大术中风险,因此在相当多的病例中可能会影响胸膜感染的充分切除或有效手术管理。我们展示了3例成功的非标签胸主动脉内植入术病例,以保障胸主动脉壁的完整性。
所有患者均通过股动脉途径将胸主动脉覆膜支架输送至降主动脉,第一例患者在接受新辅助放化疗后,切除了浸润降主动脉壁的左下叶局部晚期鳞状细胞癌(cT4cN0-1cM0)。第二例患者因坏死性胰腺炎合并胰胸瘘,行电视辅助胸腔镜双侧胸膜纤维板剥脱术,治疗伴有胸主动脉远端溃疡的脓胸。第三例患者在接受新辅助放化疗后,因左下叶局部晚期鳞状细胞癌(初始阶段cT4 cN1-2 cM0)接受手术,该肿瘤在第7和第8胸椎水平与降主动脉广泛接触,接触范围约180°。根据瑞士联邦人类研究法案,已按规定获得地区伦理委员会批准。
预防性植入覆膜支架实现了无并发症切除,并显著降低了术中致命性出血的风险。患者因此未暴露于与主动脉阻断、可能的人工血管置换及体外循环技术相关的并发症。
在精心挑选的患者群体中,术前通过胸主动脉腔内修复术可促进累及主动脉壁的局部晚期肿瘤或感染性病变的切除。